Placebo to match SNG001 (Interferon beta-1a 12MIU/mL solution for inhalation) clinical trials

A phase 2, two-part study to assess the safety, antiviral biomarker responses, and efficacy of inhaled SNG001 for the treatment of patients with a confirmed respiratory virus infection undergoing invasive mechanical ventilation

This study is looking at a new inhaled medicine, SNG001, for people in hospital with lung infections caused by viruses. We want to see if it's safe, helps the body fight the virus, and improves recovery for those needing breathing support.